NRBP2 is one of the pseudokinases discovered during neural differentiation gene screening, which can inhibit the progression of various cancers such as medulloblastoma and hepatocellular carcinoma [24]. This evidence concerns the gene NRBP2 and hepatocellular carcinoma.